Chemed Corp. (NYSE:CHE) shares hit a new 52-week high during mid-day trading on Friday after the company announced a dividend. The stock traded as high as $233.81 and last traded at $0.00, with a volume of shares changing hands. The newly announced dividend which will be paid on Monday, December 4th. Shareholders of record on Monday, November 13th will be given a $0.28 dividend. The ex-dividend date of this dividend is Friday, November 10th. Chemed Corp.’s payout ratio is 24.89%.

A number of equities analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $216.00 price objective on the stock in a research report on Monday, September 18th. KeyCorp assumed coverage on shares of Chemed Corp. in a research report on Monday, August 28th. They issued a “sector weight” rating on the stock. Oppenheimer Holdings, Inc. boosted their price objective on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a research report on Thursday, July 27th. TheStreet lowered shares of Chemed Corp. from a “b+” rating to a “c+” rating in a research note on Tuesday, July 25th. Finally, Royal Bank Of Canada reaffirmed a “hold” rating and set a $209.00 target price on shares of Chemed Corp. in a research note on Monday, July 31st. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $236.00.

The company has a market capitalization of $3,752.17, a P/E ratio of 28.94, a price-to-earnings-growth ratio of 4.97 and a beta of 1.14. The company has a current ratio of 0.50, a quick ratio of 0.48 and a debt-to-equity ratio of 0.15.

Chemed Corp. (NYSE:CHE) last announced its earnings results on Thursday, October 26th. The company reported $2.15 earnings per share for the quarter, beating analysts’ consensus estimates of $2.00 by $0.15. The firm had revenue of $417.40 million for the quarter, compared to analyst estimates of $414.34 million. Chemed Corp. had a net margin of 4.62% and a return on equity of 27.69%. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.73 EPS. analysts forecast that Chemed Corp. will post 4.73 EPS for the current year.

In related news, CEO Kevin J. Mcnamara sold 10,000 shares of the business’s stock in a transaction dated Tuesday, October 31st. The shares were sold at an average price of $223.42, for a total transaction of $2,234,200.00. Following the sale, the chief executive officer now owns 170,016 shares of the company’s stock, valued at $37,984,974.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Spencer S. Lee sold 1,000 shares of the business’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $197.46, for a total transaction of $197,460.00. Following the sale, the insider now directly owns 37,809 shares in the company, valued at approximately $7,465,765.14. The disclosure for this sale can be found here. Insiders have sold a total of 13,250 shares of company stock worth $2,927,418 in the last ninety days. Insiders own 4.90% of the company’s stock.

A number of large investors have recently bought and sold shares of the stock. Kalos Management Inc. boosted its stake in Chemed Corp. by 0.7% during the second quarter. Kalos Management Inc. now owns 6,521 shares of the company’s stock worth $1,333,000 after acquiring an additional 45 shares in the last quarter. Capstone Asset Management Co. boosted its stake in Chemed Corp. by 2.7% during the second quarter. Capstone Asset Management Co. now owns 1,857 shares of the company’s stock worth $380,000 after acquiring an additional 49 shares in the last quarter. Nisa Investment Advisors LLC boosted its stake in Chemed Corp. by 0.4% during the second quarter. Nisa Investment Advisors LLC now owns 11,600 shares of the company’s stock worth $2,373,000 after acquiring an additional 50 shares in the last quarter. Amalgamated Bank boosted its stake in Chemed Corp. by 2.9% during the second quarter. Amalgamated Bank now owns 2,203 shares of the company’s stock worth $451,000 after acquiring an additional 62 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System boosted its stake in Chemed Corp. by 0.7% during the second quarter. State Board of Administration of Florida Retirement System now owns 8,681 shares of the company’s stock worth $1,776,000 after acquiring an additional 64 shares in the last quarter. 97.24% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Chemed Corp. (CHE) Reaches New 1-Year High Following Dividend Announcement” was first reported by Watch List News and is owned by of Watch List News. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://www.watchlistnews.com/chemed-corp-che-reaches-new-1-year-high-following-dividend-announcement/1679863.html.

Chemed Corp. Company Profile

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.

Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.